Today: 17 January 2026
Subscribe
Browse Category

Health Insurance News 29 November 2025 - 18 December 2025

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Incorporated (NYSE: UNH) stock is ending a volatile 2025 with fresh headline risk—and a handful of potentially meaningful catalysts—front and center on December 18, 2025. Shares traded around $326–$327 in midday trading, after moving between roughly $324.66 and $330.50 intraday. While UnitedHealth remains one of the most closely watched blue-chip healthcare names, 2025 has been defined by unusually…
18 December 2025
····
UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group Incorporated (NYSE: UNH) finished the week with a notable rebound, closing Friday, December 12, 2025 at $341.84, up 1.52% on the day—outperforming a broader market that sold off into the weekend. Investing The move capped a choppy five-session stretch that began with a sharp Monday drop and then reversed higher for most of the week—while investors weighed a…
13 December 2025
····
UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth Group Incorporated (NYSE: UNH) ended the Friday, December 12, 2025 session on a relative high note—rising even as the broader market slid—and then traded modestly lower in the first hour of after-hours action. StockAnalysis If you’re tracking UNH into the weekend, there’s one scheduling detail to keep straight: December 13, 2025 is a Saturday, meaning U.S. stock markets are…
12 December 2025
····
Elevance Health Stock (NYSE: ELV) News Today: Credit Ratings, ACA Subsidy Vote, and Analyst Forecasts on Dec. 12, 2025

Elevance Health Stock (NYSE: ELV) News Today: Credit Ratings, ACA Subsidy Vote, and Analyst Forecasts on Dec. 12, 2025

Elevance Health, Inc. (NYSE: ELV) is drawing fresh investor attention on December 12, 2025 as credit-rating updates and U.S. policy headlines collide with a stock that has recently rebounded sharply. The latest developments arrive at a sensitive moment for managed-care names, with Wall Street weighing medical-cost trends, Medicaid rate dynamics, and the looming Affordable Care Act (ACA) subsidy deadline. As…
12 December 2025
···
Elevance Health (ELV) Stock News Today: ACA Subsidy Deadline Looms, Fitch Affirms A- Rating, and Analysts See Modest Upside (Dec. 12, 2025)

Elevance Health (ELV) Stock News Today: ACA Subsidy Deadline Looms, Fitch Affirms A- Rating, and Analysts See Modest Upside (Dec. 12, 2025)

Elevance Health (NYSE: ELV) is stabilizing near the $360 level after a sharp rebound, while Washington’s failure to extend ACA subsidies raises new 2026 uncertainty. Here’s the latest news, credit outlook, analyst forecasts, and technical setup as of December 12, 2025. Published: December 12, 2025 Elevance Health, Inc. (NYSE: ELV ) is ending the week with investors balancing two powerful…
12 December 2025
···
UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group Incorporated (NYSE: UNH) stock is back in focus on December 12, 2025, after a strong Thursday rebound put the health-insurance giant near a closely watched technical zone around $340—while investors continue to weigh a busy mix of antitrust and legal headlines, Medicare-related scrutiny, medical cost trend pressures, and 2026 recovery expectations. UNH stock price check: where UnitedHealth shares…
12 December 2025
···
Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health (OSCR) Stock Today: Fresh Analyst Coverage, Big 2027 Profit Hopes and Policy Risk in Focus

Oscar Health, Inc. (NYSE: OSCR) is back under the market’s spotlight on December 11, 2025, as Wall Street adds new coverage, doubles down on long‑term profit targets, and investors digest another bout of volatility in this high‑growth, high‑risk health‑insurtech name. While legacy giants such as American International Group, Inc. (AIG) dominate traditional insurance lines, Oscar is trying to reinvent health…
11 December 2025
··
Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health (OSCR) Stock: Can a 35% Rally Survive Fresh Downgrades and ACA Uncertainty? – December 7, 2025

Oscar Health Inc. (NYSE: OSCR) has just delivered one of the wildest weeks in its short public-market life: the stock jumped roughly 35% on hopes that the White House will extend Affordable Care Act (ACA) subsidies, then ran straight into a wall of new downgrades and rising bearish options activity. Investopedia As of the latest close, Oscar shares trade around…
7 December 2025
····
Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast

Date: December 4, 2025Ticker: Humana Inc. (NYSE: HUM) Humana’s share price spent most of 2025 behaving like a stressed-out cardiogram: sharp drops around guidance cuts and star-rating headlines, then sharp rebounds when the numbers looked less bad than feared. As of early trading on December 4, Humana stock is changing hands in the mid‑$250s, down roughly 12% over the past…
4 December 2025
···
Mumbai Consumer Commission Orders Niva Bupa To Pay ₹66.5 Lakh For Overseas Cancer Treatment: What The Landmark Ruling Means For Health Insurance Customers

Mumbai Consumer Commission Orders Niva Bupa To Pay ₹66.5 Lakh For Overseas Cancer Treatment: What The Landmark Ruling Means For Health Insurance Customers

The Mumbai Suburban District Consumer Disputes Redressal Commission has directed Niva Bupa Health Insurance Company Ltd to pay ₹66.5 lakh to a Juhu-based cancer patient after holding that the insurer wrongfully cancelled his policy and denied his overseas treatment claim. The order, now widely reported across legal and financial media as of December 4, 2025, is being described as one…
4 December 2025
·
UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth Group (UNH) Stock Update – November 30, 2025: Fresh Valuation Warnings, New Buyers, and Persistent Regulatory Risk

UnitedHealth Group Incorporated (NYSE: UNH) heads into the final weeks of 2025 as one of the most watched – and most controversial – stocks in the Dow. As of the last trading session on Friday, November 28, UnitedHealth closed around $329.77 per share, implying a market capitalization of roughly $299 billion. StockAnalysis That price comes after a brutal year: UNH’s…
30 November 2025
····
UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group (UNH) Stock on 29 November 2025: DOJ Probe, Medicare Advantage Shake‑Up and a 45% Slide

UnitedHealth Group Incorporated (NYSE: UNH) has gone from defensive market darling to one of 2025’s most controversial blue‑chips. As of 29 November 2025, the stock is trading around $330 per share, down roughly 45% over the past year, even after a modest rebound in late November. StockAnalysis At the same time, the company is raising its full‑year earnings outlook, reshaping…
29 November 2025
···
1 2 3 4 5

Stock Market Today

  • IGO's momentum and webcast plan shape investment narrative in battery minerals era
    January 17, 2026, 3:53 PM EST. IGO Ltd's stock has strengthened on ASX technical uptrend signals as the miner gears up for a late-January webcast to review December 2025 results. Lithium prices have fallen and supply appears stabilizing, but investors are focusing more on IGO's role in the battery minerals sector and upcoming disclosures. The market sees momentum in lithium-related equities as a short-term catalyst, even as IGO remains loss-making with forecast revenue contraction and no interim dividend. The webcast is expected to frame cash flows, production guidance and capital allocation following a A$954.6 million loss. Ausbil exited as a substantial holder, reducing but not changing the core risk that valuation relies on future earnings recovery. Near-term funding and earnings risk remains.
Go toTop